A personalized approach to the surgical treatment of early-stage uterine body cancer with tumor involvement in the lower uterine segment. Clinical observation

In the Russian Federation, the incidence of uterine body cancer remains the highest among malignant neoplasms of the female genital organs. Surgical treatment is the primary method for treating early stages of the disease; however, the issue of predicting metastatic lymph node involvement at the preoperative stage for performing lymphadenectomy remains debatable. The potential prognostic significance of tumor involvement in the lower uterine segment regarding lymph node metastases may justify the need to assess tumor localization before starting treatment. Magnetic resonance imaging (MRI) of the pelvic organs can help determine the involvement of the lower uterine segment in the tumor process, thereby creating a basis for expanding the scope of surgical intervention. © 2024, LLC MMA MediaMedika. All rights reserved.

Authors
Tkachenko B.E. , Mkrtchyan L.S. , Levickaya N.V. , Agababyan T.A. , Sheberova E.V. , Ushakova D.A. , Petrov V.A. , Ivanov S.A. , Kaprin A.D.
Publisher
ООО "МедиаФормат"
Number of issue
7
Language
Russian
Pages
69-73
Status
Published
Volume
5
Year
2024
Organizations
  • 1 Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre, Obninsk, Russian Federation
  • 2 Patrice Lumumba People’s Friendship University of Russia (RUDN University), Moscow, Russian Federation
  • 3 Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, Moscow, Russian Federation
  • 4 National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Keywords
endometrioid adenocarcinoma; indocyanine green; lower uterine segment; magnetic resonance imaging; risk factor; sentinel lymph node; uterine body cancer

Other records